Overview

Gotu Kola (Centella asiatica) is a perennial herb from the Apiaceae family that has been used for centuries in traditional Ayurvedic, Chinese, and Southeast Asian medicine. It grows in tropical and subtropical regions and is prized for its adaptogenic, cognitive-enhancing, and wound-healing properties. The primary bioactive compounds are pentacyclic triterpenes, including asiaticoside, madecassoside, asiatic acid, and madecassic acid, which are collectively known as centelloids.

The wound-healing and skin-regeneration properties of Gotu Kola are among its most well-documented effects. Asiaticoside and madecassoside stimulate collagen synthesis (types I and III), promote fibroblast proliferation, and increase angiogenesis at wound sites. These properties have led to its inclusion in topical preparations for scar management, burns, and chronic venous insufficiency. When used alongside peptides like GHK-Cu and BPC-157, Gotu Kola may provide complementary support for tissue repair through both systemic and topical routes.

As a nootropic, Gotu Kola has been studied for its anxiolytic effects and its ability to enhance memory and cognitive function. Research suggests it modulates GABAergic pathways and may promote dendritic growth and neurite elongation. Typical dosing for standardized extracts ranges from 250–750 mg daily (standardized to 40% triterpenes). It is generally well tolerated, though hepatotoxicity has been reported in rare cases with prolonged high-dose use. Gotu Kola pairs well with other nootropics such as Lion's Mane and Bacopa in cognitive support stacks.

Mechanism of Action

Gotu Kola (Centella asiatica) is a medicinal herb whose therapeutic effects are primarily attributed to its triterpenoid saponins: asiaticoside, madecassoside, asiatic acid, and madecassic acid. The wound healing and skin repair properties are mediated through activation of the TGF-β/Smad signaling pathway, which stimulates fibroblast proliferation and significantly increases synthesis of type I and type III collagen—the primary structural proteins of the extracellular matrix in skin and connective tissue.

The antioxidant effects of Gotu Kola are mediated through activation of the Nrf2 transcription factor pathway. Triterpenoids promote Nrf2 nuclear translocation, where it binds to antioxidant response elements (AREs) and upregulates expression of protective enzymes including superoxide dismutase (SOD), catalase (CAT), and heme oxygenase-1 (HO-1). Simultaneously, Gotu Kola inhibits the NF-κB signaling pathway, reducing production of pro-inflammatory cytokines (TNF-α, IL-1β) and inflammatory enzymes (COX-2, iNOS). MAPK pathway modulation (ERK, JNK, p38) further contributes to its anti-inflammatory and cytoprotective effects.

Neuroprotective properties involve increased expression of brain-derived neurotrophic factor (BDNF), which supports neuronal growth, survival, and synaptic plasticity. The PI3K/Akt and Wnt/β-catenin pathways are also implicated in Gotu Kola's wound healing and neuroprotective effects. Asiatic acid in particular has demonstrated the ability to cross the blood-brain barrier, making it relevant for cognitive enhancement and neurodegenerative disease research. The combination of collagen-promoting, antioxidant, anti-inflammatory, and neurotrophic mechanisms makes Gotu Kola a multi-target botanical compound.

Reconstitution Calculator

Research

Safety Profile

Safety Profile: Gotu Kola (Centella asiatica)

Common Side Effects

• Mild gastrointestinal upset (nausea, stomach pain, diarrhea)
• Headache and dizziness
• Drowsiness and sedation
• Skin irritation with topical application (contact dermatitis)
• Increased sun sensitivity (photosensitivity) in some individuals
• Mild itching at application site (topical use)

Serious Adverse Effects

• Hepatotoxicity: Multiple case reports of liver injury, including jaundice and elevated liver enzymes, particularly with prolonged use (>6 weeks continuous) or high doses
• Allergic reactions: Contact dermatitis (topical), and rare systemic allergic reactions
• Hyperlipidemia: Paradoxical elevation of lipids reported in isolated cases
• Infertility concerns: Animal studies suggest potential antifertility effects at high doses
• Elevated blood glucose: Reported in some animal models; clinical significance uncertain

Contraindications

• Known allergy to Centella asiatica or other Apiaceae (carrot/celery family) plants
• Active liver disease or history of hepatotoxicity
• Pregnancy (potential abortifacient effects in animal studies) and lactation
• Scheduled surgery (discontinue at least 2 weeks prior due to potential sedative interactions with anesthesia)
• Children under 18 (insufficient safety data for oral supplementation)

Drug Interactions

• Hepatotoxic drugs (acetaminophen, statins, ketoconazole): Additive liver injury risk; monitor LFTs
• Sedatives and CNS depressants (benzodiazepines, barbiturates, alcohol): Enhanced drowsiness and sedation
• Diabetes medications: May affect blood glucose levels; monitor closely
• Cholesterol-lowering drugs: Potential interaction with lipid metabolism
• Diuretics: Gotu kola has mild diuretic properties; may potentiate effects
• CYP450 substrates: Limited data on enzyme inhibition; exercise caution with narrow-therapeutic-index drugs

Population-Specific Considerations

• Pregnancy/Lactation: Contraindicated; animal studies show embryotoxic effects. Avoid during breastfeeding due to insufficient safety data
• Children: Not recommended for oral supplementation; topical use for wound healing may be acceptable under medical supervision
• Elderly: Start with low doses; monitor hepatic function and sedation levels
• Liver disease: Avoid use; documented cases of hepatotoxicity
• Surgical patients: Discontinue 2 weeks before surgery
• Duration of use: Cycle use (2-4 weeks on, 1-2 weeks off) is commonly recommended to reduce hepatotoxicity risk

Pharmacokinetic Profile